FierceBiotech

BD, Babson set sights on bringing simple blood collection into the home

Babson’s device aims to coax out the blood without using the same pressure that plagued previous attempts at fingerstick blood tests—most famously pursued by the failed company Theranos. (Babson ...

Capillary Blood Collection Devices Market to Value USD 4.86 Billion by 2035, Expanding at an 8.26% CAGR – SNS Insider

U.S. Market to Surpass USD 1.31 Billion and Europe Market to Reach USD 1.34 Billion by 2035 as Diabetes Monitoring and Point-of-Care Diagnostics Accelerate Demand.Austin, United States, June 15, 2026 ...
FierceBiotech

BD, Babson Diagnostics expand fingertip blood draws to urgent care clinics, doctors' offices

Babson’s BetterWay sample prep system was initially aimed at broadening the possibilities of blood collection in retail locations such as pharmacies and grocery stores. (Babson Diagnostics) Longtime ...
MD&M East

Babson Unlocks Critical Milestone Ahead of Commercialization

The company that aims to succeed where Theranos failed just achieved a critical milestone ahead of bringing its BetterWay blood testing service to market next year. FDA recently cleared the BD ...
Healio

FDA clears novel blood collection device

Please provide your email address to receive an email when new articles are posted on . The BD MiniDraw device is part of a blood testing collection system that is designed to make routine blood tests ...
Business Wire

Babson Diagnostics’ BetterWay™ Blood Testing Service Achieves Critical Milestone Ahead of Commercialization

AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...